Thursday, October 15, 2026
Source trace. Via News points to the documents behind its reporting and shows what we drew from each — so you can check any claim. How we source
Source document· February 5, 2026

No Deposit Bonus Casinos Canada 2026: BitStarz Rolls Out Instant 50 Free Spins With New Promo Code

View original at globenewswire.com
No Deposit Bonus Casinos Canada 2026: BitStarz Rolls Out Instant 50 Free Spins With New Promo Code New York City, NY, Feb. 05, 2026 (GLOBE NEWSWIRE) -- No deposit bonuses are popular among players for offering risk-free gaming, yet high wagering requirements and uneasy terms often limit how easily they can be used…
Opening lines of the source · short snapshot — read the full document at the original

What we drew from this source

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • BitStarz's average payout speed is approximately 7.5 minutes

    80% confidence
  • BitStarz offers 50 no deposit free spins with a competitive wagering requirement of 40x soon after signing up

    80% confidence
  • The 40x wagering requirement is low compared to other online casino signup bonuses

    80% confidence
  • BitStarz VIP program is one of the exclusive packages ever available among the best no deposit bonus casinos Canada

    80% confidence

Data points we hold from this source

BitStarz Casino · live dealer minimum rtp94 percent
BitStarz Casino · live dealer games150 games
BitStarz Casino · original games10 games
BitStarz Casino · game count5000 games
BitStarz Casino · table games average rtp95 percent
What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Q4 2026 Clinical Catalyst Season: Big-Pharma Data Flow, Regulatory Milestones, and a Thin AI-Drug Fringe
October 2026 conferences (EASD, IGCS, NACFC, HFSA) are producing a dense run of late-stage readouts from Novo Nordisk, Lilly, Roche, Bayer, Vertex and Galderma. Regulatory milestones are scheduled behind them: the ivonescimab BLA PDUFA date on 2026-11-14, FDA acceptance of Roche's vamikibart BLA, and Scholar Rock's EMA resubmission. The AI-and-finance angle is peripheral. It consists of the AI-designed drug Rentosertib and QAIAx, a speculative microcap whose trial claims (the QIII pilot, anticipated 2027-01-01, and a patent update) are forecasts and filings rather than data, so they warrant skepticism.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
ING Group
Both facts record the same metric (shares_outstanding) for ING Group at the identical observation date (2025-12-31). FACT A states 2,902,437,688 shares; FACT B states 2,902 million shares (2,902,000,000). The difference is 437,688 shares (~0.015%). This is a genuine value conflict, though the discrepancy appears to result from FACT B rounding to the nearest million while FACT A provides the precise count.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,986
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,986 facts checked against source5,375 source documents archived
Query this data → isubstrate.com
No Deposit Bonus Casinos Canada 2026: BitStarz Rolls Out Instant 50 Free Spins With New Promo Code — Source | Via News | Via News